Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02791581 · ClinicalTrials.gov registry record · NA
Understanding and Predicting Breast Cancer Events After Treatment
A NA study of Breast Cancer, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 403
- Enrollment target
- 20
- Study locations
NCT02791581 is a NA study of Breast Cancer that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 403 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT02791581, a NA study of Breast Cancer, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 403 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not have cancer.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac MRI
Study Locations (20)
Michigan
- University of Michigan Comprehensive Cancer Center - Ann Arbor
- Beaumont Hospital - Dearborn - Dearborn
- Beaumont Hospital - Farmington Hills - Farmington Hills
- Spectrum Health at Butterworth Campus - Grand Rapids
- William Beaumont Hospital-Royal Oak - Royal Oak
- William Beaumont Hospital - Troy - Troy
Indiana
- IU Health North Hospital - Carmel
- Indiana University/Melvin and Bren Simon Cancer Center - Indianapolis
- Springmill Medical Center - Indianapolis
Minnesota
- Saint John's Hospital - Healtheast - Maplewood
- Abbott-Northwestern Hospital - Minneapolis
- Health Partners Inc - Minneapolis
Florida
- Moffitt Cancer Center - McKinley Campus - Tampa
- Moffitt Cancer Center - Tampa
Kansas
- University of Kansas Cancer Center - Kansas City
- University of Kansas Hospital-Westwood Cancer Center - Westwood
Alabama
- University of Alabama at Birmingham Cancer Center - Birmingham
District of Columbia
- MedStar Washington Hospital Center - Washington D.C.
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2017-07-21 |
| Est. Completion | 2034-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02791581
The ClinicalTrials.gov registry entry for NCT02791581 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 403 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (86% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Cardiac MRI is the first listed.
NCT02791581 reports 20 study locations spanning 9 distinct geographic areas - top geographies include Michigan, Indiana, Minnesota.
Frequently Asked Questions
What is clinical trial NCT02791581 about?
NCT02791581 is a clinical study titled "Understanding and Predicting Breast Cancer Events After Treatment". This study is being done to see if patients receiving chemotherapy for breast cancer affects the heart, the ability to exercise and fatigue when compared to patients who do not have cancer.
What is the current status of trial NCT02791581?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 403 participants. The study started on 2017-07-21. Estimated completion is 2034-07-31.
What conditions does trial NCT02791581 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT02791581?
The interventions under investigation include: Cardiac MRI (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT02791581?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02791581 being conducted?
This trial has 20 study locations across Alabama, District of Columbia, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.